Atossa Therapeutics, Inc. (ATOS)
2.65
-0.03
(-1.12%)
USD |
NASDAQ |
Aug 26, 16:00
2.67
+0.02
(+0.75%)
After-Hours: 20:00
Atossa Therapeutics Market Cap : 26.45M for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 26.45M |
| August 25, 2026 | 26.74M |
| August 24, 2026 | 26.35M |
| August 21, 2026 | 25.35M |
| August 20, 2026 | 25.85M |
| August 19, 2026 | 26.35M |
| August 18, 2026 | 25.85M |
| August 17, 2026 | 27.84M |
| August 14, 2026 | 25.95M |
| August 13, 2026 | 25.55M |
| August 12, 2026 | 23.45M |
| August 11, 2026 | 23.55M |
| August 10, 2026 | 23.65M |
| August 07, 2026 | 23.55M |
| August 06, 2026 | 24.15M |
| August 05, 2026 | 23.85M |
| August 04, 2026 | 19.89M |
| August 03, 2026 | 18.69M |
| July 31, 2026 | 17.83M |
| July 30, 2026 | 18.86M |
| July 29, 2026 | 19.89M |
| July 28, 2026 | 20.80M |
| July 27, 2026 | 20.32M |
| July 24, 2026 | 19.76M |
| July 23, 2026 | 20.75M |
| Date | Value |
|---|---|
| July 22, 2026 | 20.93M |
| July 21, 2026 | 20.67M |
| July 20, 2026 | 21.44M |
| July 17, 2026 | 21.44M |
| July 16, 2026 | 20.58M |
| July 15, 2026 | 21.01M |
| July 14, 2026 | 19.46M |
| July 13, 2026 | 20.67M |
| July 10, 2026 | 20.41M |
| July 09, 2026 | 20.32M |
| July 08, 2026 | 21.10M |
| July 07, 2026 | 21.44M |
| July 06, 2026 | 19.63M |
| July 02, 2026 | 18.26M |
| July 01, 2026 | 17.57M |
| June 30, 2026 | 16.62M |
| June 29, 2026 | 17.05M |
| June 26, 2026 | 16.19M |
| June 25, 2026 | 15.24M |
| June 24, 2026 | 15.07M |
| June 23, 2026 | 16.36M |
| June 22, 2026 | 15.76M |
| June 18, 2026 | 17.31M |
| June 17, 2026 | 17.09M |
| June 16, 2026 | 19.12M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Immix Biopharma, Inc. | 1.007B |
| ACADIA Pharmaceuticals, Inc. | 5.092B |
| Alnylam Pharmaceuticals, Inc. | 31.96B |
| Anika Therapeutics, Inc. | 290.14M |
| Savara, Inc. | 1.152B |
Market Cap Related Metrics
| PEG Ratio | -0.0045 |
| Price to Book Value | 0.9857 |
| Price | 2.65 |
| Earnings Yield | -164.0% |
| PEGY Ratio | -0.0045 |